Biotech firms raised $1.8 billion in Q3 venture funding

11/4/2011 | MassDevice.com (Boston)

Life sciences firms secured $1.8 billion in venture capital investments during the third quarter with 170 deals, an 18% drop from the second quarter, according to a PricewaterhouseCoopers report. Tracy Lefteroff of PwC US pointed to regulatory challenges, difficulty with IPOs and equity market volatility as reasons.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA